Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.

Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.
复制标题

DOI:
10.1038/s41598-020-76785-w
复制
发表时间:
2020-11-26
期刊:
影响因子:
4.6
通讯作者:
University of Kentucky CRRT Quality Assurance Group
University of Kentucky CRRT Quality Assurance Group
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Ruiz EF;Ortiz-Soriano VM;Talbott M;Klein BA;Thompson Bastin ML;Mayer KP;Price EB;Dorfman R;Adams BN;Fryman L;Neyra JA;University of Kentucky CRRT Quality Assurance Group

文献摘要

参考文献

被引文献

相似文献

需要连续肾脏替代治疗 (CRRT) 的危重患者代表了重症监护病房 (ICU) 人群的不断增长。最佳 CRRT 实施需要利益相关者之间的持续沟通、治疗的迭代调整和质量保证系统。这项质量改进 (QI) 研究报告了支持在 ICU 提供 CRRT 的质量保证体系的开发、实施和结果。这项研究于 2016 年 9 月至 2019 年 6 月在肯塔基大学医学中心进行。我们采用逐步方法实施了质量保证体系,该方法基于 (a) 组建多学科团队,(b) CRRT 协议标准化,(c) 创建电子 CRRT 流程图,(d) 选择、监测和报告 CRRT 可交付成果的质量指标,以及 (e) 加强教育。我们检查了 1185 名接受 CRRT 的成年患者(约 7420 个 CRRT 患者日)的 34 个月数据,并跟踪了 CRRT 实施的选定 QI 结果/指标。通过 QI 干预措施,我们增加了 CRRT 团队中多学科专家的数量,并确保了医疗保健专业人员的持续教育。我们将连续静脉-静脉血液透析滤过的使用最大化至 100%,并将使用局部柠檬酸盐抗凝的患者比例增加了一倍。在研究期间,输送的 CRRT 流出物剂量(~ 30 ml/kg/h)和输送/规定的流出物剂量比(~ 0.89)保持稳定。尽管 CRRT 持续时间和死亡率相似,但平均过滤器寿命从 26 小时增加到 31 小时 (p = 0.020),将每个患者的过滤器平均利用率从 3.56 减少到 2.67 (p = 0.054)。每个治疗日的 CRRT 访问警报数量减少了 43%。过滤器利用率的提高意味着每 100 名接受 CRRT 的患者可节省 20,000 美元的过滤器成本。我们令人满意地开发并实施了在 ICU 中提供 CRRT 的质量保证系统,从而实现了 CRRT 可交付成果的可持续跟踪,并减少了我们机构的过滤资源利用率。
Critically ill patients with requirement of continuous renal replacement therapy (CRRT) represent a growing intensive care unit (ICU) population. Optimal CRRT delivery demands continuous communication between stakeholders, iterative adjustment of therapy, and quality assurance systems. This Quality Improvement (QI) study reports the development, implementation and outcomes of a quality assurance system to support the provision of CRRT in the ICU. This study was carried out at the University of Kentucky Medical Center between September 2016 and June 2019. We implemented a quality assurance system using a step-wise approach based on the (a) assembly of a multidisciplinary team, (b) standardization of the CRRT protocol, (c) creation of electronic CRRT flowsheets, (d) selection, monitoring and reporting of quality metrics of CRRT deliverables, and (e) enhancement of education. We examined 34-month data comprising 1185 adult patients on CRRT (~ 7420 patient-days of CRRT) and tracked selected QI outcomes/metrics of CRRT delivery. As a result of the QI interventions, we increased the number of multidisciplinary experts in the CRRT team and ensured a continuum of education to health care professionals. We maximized to 100% the use of continuous veno-venous hemodiafiltration and doubled the percentage of patients using regional citrate anticoagulation. The delivered CRRT effluent dose (~ 30 ml/kg/h) and the delivered/prescribed effluent dose ratio (~ 0.89) remained stable within the study period. The average filter life increased from 26 to 31 h (p = 0.020), reducing the mean utilization of filters per patient from 3.56 to 2.67 (p = 0.054) despite similar CRRT duration and mortality rates. The number of CRRT access alarms per treatment day was reduced by 43%. The improvement in filter utilization translated into ~ 20,000 USD gross savings in filter cost per 100-patient receiving CRRT. We satisfactorily developed and implemented a quality assurance system for the provision of CRRT in the ICU that enabled sustainable tracking of CRRT deliverables and reduced filter resource utilization at our institution.
DOI: 10.1111/j.1525-139x.2011.00835.x
发表时间: 2011-03-01
影响因子: 1.6
作者:
Graham, Patricia;Lischer, Eileen
通讯作者: Lischer, Eileen
DOI: 10.2215/cjn.00710113
发表时间: 2013-09-06
影响因子: 9.8
作者:
Susantitaphong, Paweena;Cruz, Dinna N.;Jaber, Bertrand L.
通讯作者: Jaber, Bertrand L.
DOI: 10.1159/000448507
发表时间: 2016-01-01
期刊: BLOOD PURIFICATION
影响因子: 3
作者:
Bagshaw, Sean M.;Chakravarthi, Madarasu Rajasekara;Ronco, Claudio
通讯作者: Ronco, Claudio
DOI: 10.1186/s13054-014-0454-8
发表时间: 2014-01-01
期刊: CRITICAL CARE
影响因子: 15.1
作者:
Oh, Hyung Jung;Lee, Mi Jung;Yoo, Tae-Hyun
通讯作者: Yoo, Tae-Hyun
DOI: 10.1186/s12882-017-0445-5
发表时间: 2017-02-20
期刊: BMC nephrology
影响因子: 2.3
作者:
Brain M;Winson E;Roodenburg O;McNeil J
通讯作者: McNeil J